Éèç€ã®çš®åã¯æçšã§ããïŒ
äžè¢éèç€ç¡¬åçæ³ïŒæ¶²ç¶ç¡¬åçæ³ãããã©ãŒã 硬åçæ³ãžïŒ å «å·» é éïš å¹¹åŒ æ«»äº è£ä¹ å¯å³¶ äžå æ²³é 倪é 濱ç æ·³ç èŠ æšïŒäžè¢éèç€ã«å¯Ÿãã硬åçæ³ã®æŽå²ã¯å€ãïŒ1840幎代ã«ããã®ãŒãããã®åŸïŒçš®ã ã®è¬.äžè¢éèç€çäŸ9 2017/05/27 äžè¢éèç€çäŸ8 2017/05/25 äžè¢éèç€çäŸ7ãšææ°æ²»çã«ã€ããŠã®ãçŽ¹ä» 2017/05/17 äžè¢éèç€çäŸ6 2017/05/12 äžè¢éèç€çäŸ5 2017/05/06 äžè¢éèç€çäŸ4 2017/05/01 äžè¢éèç€çäŸ3 2017/04/20 äžè¢éèç€çäŸ2 2017/04/10 äžè¢éèç€çäŸ1.1ïŒèéèç€ã«å¯Ÿããbârto âçµå€§è ¿ã¢ãããŒããäžå¿ã«â åç°åŒåœ°ã»ã 2ïŒèéèç€ã«å¯Ÿããbârto âé žéèã¢ãããŒããäžå¿ã«â ç§å·æ¿åã»ã 3ïŒèéèç€ä»¥å€ã®éè倧埪ç°ç絡路ã«å¯Ÿããbârto 西ç°å žå². ã ã³ããŒã·ã£ã³.äžè¢éèç€ã¯30æ³ä»¥äžã®6å²ã«èªãããããããç¥çµãæŽåœ¢å€ç§ççŸæ£ãšå䜵ããããšãå°ãªããããŸããããŸãåèçŸæ£ã§ãæŽåœ¢å€ç§ççŸæ£ãšã®å䜵ãèªãããããã®å Žåã¯äž¡çŸæ£ã®æ²»çãå¿ èŠã«ãªã£ãŠããŸãã å€æ¥ã§ã®èšºå¯ããã³æ²»çã¯ïŒ.ãšã¿ããŒã«ã¯å ç®çŽ°èã«æ°žä¹ çãªé害ãåŒãèµ·ãããŸãïŒãªã«ããã³ïŒ ethanolamine oleateïŒã¯ãé°ã€ãªã³ç³»çé¢æŽ»æ§å€ã§ãäžè¢ãé£éã»èã®éèç€ã®ç¡¬åå€ãšããŠäœ¿çšãããŠãããéèæ§è¡ç®¡å¥åœ¢ã«ã䜿çšãããããã«ãªããŸããïŒããªãã«ããŒã«ãæ¬æ¥ã¯.ã粟玢éèç€ïŒãããããããã¿ãããã ãïŒãã¯ã粟巣ïŒçŸäžžïŒã®éèã«ã§ããè¡ç®¡ã®ç€ïŒãã¶ïŒã®ãããªãã®ã§ãäžè¬ç·æ§ã®5人ã«1人ã«èŠãããŸãïŒâ»1ïŒã.æè¡ã«ãã䟵襲ã®çšåºŠãå°ãããäžå®ã®åœ¢ã®ç€ã§ããã°ãã€ãªã¹ã¯ãªæ¹ã«ãã¡ãªããã倧ããæçšãªã®ã§ããããšã³ããªãŒã¯ãšåŒã°ããåèç€å ãžã®è¡æ¶²ã®æŒãããã¹ãã³ãã°ã©ããã®äœçœ®ç§»åã»å±æ²ã»ç Žæãé éæã®ç€æ¡å€§ã»ç Žè£ãªã©ãä»åŸæ¹åãã¹ãç¹.äžè¢éèç€ãšè¡æ çã®éã äžè¢éèç€ãšè¡æ çã®éããããåãããŸãããçŸåšäœçšéãã«ãæçšããŠããŠæ€æ»ã«è¡ãããã®ã§ãããè¡æ çãšèª¿ã¹ããšäžè¢éèç€ã®ç é¢ãå€æ°åºãŠããŸããè¡æ çã¯è¡æ¶²æ€æ»ã§dãã€ããŒãš.äžè¢éèç€ã®äžå€§èŠå ã¯ã(1)ç«ã¡ä»äºã(2)åŠåš ã»åºç£ã(3)éºäŒã§ããçŽ7察3ã®æ¯çã§å¥³æ§ãå€ãç æ°ã§ãããç·æ§ã«ãèŠãããŸããæ¥æ¬äººã®çŽ1å²ã«ãæ人女æ§ã®çŽ4å²ã®äººã«äœããã®éèç€ããããšèšãããŠããŸãã.
éèç€ã«äœ¿çšããè»èãŸãã¯ã²ã«
äžè¢éèç€ã¯ããµããã¯ãã®è¡ç®¡ããã³ãã³ãµãããŠããããšãå€ãã®ã§ããããã®ãã³ãã³ã®åå ã¯ãå®ã¯ããã®ä»ãæ ¹ããå§ãŸãã倪ããã®å åŽã«é ããŠããè¡ç®¡ïŒå€§äŒåšÂ .ãïŒå䜵ççäŸã®ç©¿åºéšã¯ïŒä»®æ§åèç€ã§ã¯ç€ãšå€§è ¿ åèã®äº€éåïŒåéèç»ã§ã¯åèãšéèãšã®ç»åãšå€ å®ããïŒä»®æ§åèç€ãšåéèã·ã£ã³ãã®å®äŸãFig. 1 ãšFig. 2ã«ç€ºããïŒ æ€æ»åã«æ£è ã«æ€æ»ã®å 容ïŒæçšæ§ã«ã€ããŠèª¬æãïŒ.Biegeleisen 5) ã«ããäžè¢ã®éèç€ã«äœ¿çšããïŒé£ ééèç€ã«å¯ŸããŠã¯ïŒ1946幎Trolle ã 6) ã«ãã£ãŠ åããŠç¡¬åå€ãšããŠäœ¿çšãããïŒæ¬éŠã§ã¯ïŒ1978 幎é«ç¬ ã 7) ã«ããé£ééèç€ã«å¯Ÿããå¡æ å€ãšã ãŠäœ¿çšããïŒãã®é«ãæçšæ§ãå ±åãããïŒ.cq22 èé£ééèç€ã«å¯ŸããŠäºé²çéèç€æ²»çã¯æçšãïŒ æšå¥šïŒèé£ééèç€ã«å¯ŸããŠäºé²çéèç€æ²»çã¯èªå·±èçåçãåäžããã åºè¡ã®ãªã¹ã¯ã軜æžããããšã§æçšã§ããäºãææ¡ããã ãšããã³ã¹ã®åŒ·ãïŒc cq23 èŸæ©èœäº¢é²çã«å¯Ÿããæ²»çã¯æçšãïŒ.è¯æ§ã®éèççªã«å¯Ÿããã¹ãã³ãç眮ã®æçšæ§ã®å ±å ã®ã»ãšãã©ã¯ïŒéæã·ã£ã³ãå¢èšåŸã«ã¿ãããå èè¥ åã«ããè é éèéå¡äŸã§ãã5ïŒ6ïŒã倧åèç€ã®å§è¿«ã« ããäžå€§éèéå¡ã«é¢ããŠã¯ïŒéèã«ç眮ããã¹ãã³.è¡ç®¡å€ç§ã§æ±ãçŸæ£ã¯å€å²ã«ããããŸãããé »åºŠã®é«ãçŸæ£ã®äžã€ã«äžè¢éèç€ããããŸãã æ¬æ¥ã¯äžè¢éèç€ãäžå¿ãšããè¡ç®¡å€ç§é åã®æŒ¢æ¹è¬æ²»çãšããŠãæ¡æè¯èäžžæãäºèæ£æãèè¬çè湯ãæŽè湯ãäžå¿ã«èšåºçæçšæ§ã®ã話ã䌺ããŸããã.硬ããªã£ãéèã¯ãå幎ãããã§åžåãããŠæ¶ããŠããŸããŸããå€æ¥ã§10åçšåºŠã§è¡ãããšãã§ããŸãã 硬åçæ³ã¯è»œçã®äžè¢éèç€ã«ã¯æçšæ§ã®é«ãæ²»çæ³ã§ãããé²è¡ããéèç€ã«ã¯æ²»çå¹æãæåŸ ã§ããªãå ŽåããããŸãã.ãã軜床ã®éèç€ïŒç¶²ç®ç¶éèç€ãªã©ïŒãç¹æ®ãªåœ¢æ ã®éèç€ã«ã¯æå¹ã§ãããéåžžã®éèç€ã§ã¯åçºçãé«ãå¹æçã§ã¯ãããŸãããããããªãããäžèš3ã€ã®æè¡åŸã«äœµçšããæ²»çæ³ãšããŠã¯æå¹ã§ãã ååãå±æ麻é ã®æ¥åž°ãæè¡ã§ãã.uncontrolledcopy é£éã»èéèç€ã®æ²»çæ¹éã決å®ããããã«ã¯æ£è ã®ç æ ãšéèè¡è¡åæ ã®ææ¡ãéèŠ ã§ããïŒéèå§äº¢é²çã®èšºæãéèè¡è¡åæ ã®ææ¡ã«ã¯ïŒè ¹éšè¶ é³æ³¢æ€æ»ïŒusïŒè¶ é³æ³¢ã.
You may look:-> éèç€äœµåç
å ç§åŠ 第10ç - é£éã»èéèç€ã®çšèªè§£èª¬ - å®çŸ©ã»æŠå¿µ æç¶çãªéèå§äº¢é²ã®ç¶æ ã«äŒŽã£ãŠïŒçççã«ååšããéè-倧埪ç°ç³»äº€éæã¯åŸãæ¡å€§ãïŒéèãã倧埪ç°ãžã®è¡æµã«ãŒããšããŠã®åœ¹å²ãæ ãããã«ãªãïŒé£éã»èéèç€ã¯ãã®éè-倧埪ç°åŽå¯è¡è¡è·¯ã®äžéšã§ããïŒé£éããã³èäžéš.ã®éèã«ã¯åŒã¯ãªãïŒéªšç€å ã®çãæ€äœã«èµ·ãããããçç±ïŒã 2. ç©¿éæïŒDodd, Boyd, Cocketâ ïŒâ ¡ïŒâ ¢ïŒç Žå£ã§éèç€ã äžè¢ã«ã¯è¡šåšéèãšæ·±éšéèãšã®éã«ç©¿éæãããã倧äŒåšéèãšæµ å€§è ¿éèã®éã«Dodd.éèç€å šè¬ Q&A. äžè¢éèç€ãšã¯äœã§ããïŒ äžè¢éèç€ãšããã®ã¯ãèïŒããïŒã®è¡šé¢ã«ããè¡ç®¡ããµãããŠããïŒãã¶ïŒã®ããã«ãªã£ãŠããŸãç æ°ã§ãã éçãªãã®ã§ã¯äžç®Â .ç§ã¯ãå€ç§ããæ¶ååšå ç§ã«ã€ãå æ¥ç°åããçè·åž«ã§ããçµæŽã¯5幎ç®ã§ãããä»ãŸã§æŽåœ¢å€ç§ã«ãããæ¶ååšå ç§ã®çŸæ£ãèŠãããšã¯ãããŸããã§ãããæè¿ãé£ééèç€ã®æ£è ãããå ¥é¢ãããŸããããç³ãéãã®éã«ãã芳å¯ããã®.粟玢éèç€ã®ã°ã¬ãŒãåé¡ïŒé¡åŸ®é¡äžç²ŸçŽ¢éèç€äœäœçµçŽ®è¡ã®é©å¿ãšã¯ïŒ é¡åŸ®é¡äžç²ŸçŽ¢éèç€äœäœçµçŽ®è¡ã¯éåžžã«ç ©éãªæè¡ã§ãããèšäº2ã§ã説æããMicro-TESEãããé«é£æ床ã§ãããããçç·Žã®ã¹ãã«ãå¿ èŠã§ãããã®ãããå®æã«ãã®è¡åŒãéžã¶ã®ã¯.2013幎3æ1æ¥ åèã匟åæ§ã«å¯ãã§ããããšããã£ãŠãå匷ãæåã«ãªãã®ã§ãã ããããéèã®æ¹ã¯ã©ãã§ãããïŒ å¿èããéèã®è¡æ¶²ãåžåŒããŠãæ»ãäœçšã¯ããã .1 è硬å€ã®éèè¡æ çã®æ²»ç Management of portal vein thrombosis in liver cirrhosis Nat Rev Gastroenterol Hepatol. 2014 ;11:435â46 ãèŠæšã éèè¡æ çã¯ïŒè硬å€ã«ããèªããããå䜵çã§ããïŒ.3ïŒé£ééèç€ã®å°åºãçæ³ïŒ4ïŒãã®ä»ïŒèååºéšæ¯ 现è¡ç®¡æ¡åŒµçã®æ²»çãªã©ã§æçšæ§ãå ±åãããŠãã1ïŒ9. apcã§ã¯ã¢ã«ãŽã³ã¬ã¹ããããŒãå 端ã§é«åšæ³¢é»æµ ã«ããã€ãªã³åããïŒã¢ã«ãŽã³ãã©ãºãæµãšãªã£ãŠ.ãŸãïŒåèãšéèãšã®éå¥ãïŒè¡æµæ³¢åœ¢ã®è©äŸ¡ã å¿ èŠãšããå Žåã¯ïŒå¿é»å³ã®åæèšé²ãæçšã§ããïŒ æ¡åŒµæ åçž®æ å¯åæ§ãã©ããïŒç¢å°ïŒãèªãïŒåŸãæ¡å€§ãç€ã圢æã ãŠããïŒ ïŒlvïŒå·Šå®€ïŒaotlïŒçè ïŒflïŒåœè ïŒ.
-> éèç€ã«å¯Ÿããrelaxsanã¿ã€ã
䌎ãçè¡ãäžå®æ蚎ã«å¯Ÿããæçšæ§ãæ€èšããïŒäžå®æ蚎ã䌎ãäžè¢ éèç€æ£è 30äŸã«æ¡æè¯èäžžã12é±éæäžãããšããïŒèªèŠçç¶ïŒ éèç€éç床ïŒçè¡ã¹ã³ã¢ã®æ¹åããã³ç®èçæµå§ã®äžæãèªãïŒ.cq4-8 é£ééèç€ã«å¯Ÿããäºé²çå èŠé¡çéèç€çµçŽ®è¡ïŒevlïŒãšå èŠé¡çéèç€ç¡¬åçæ³ïŒeisïŒã§ã¯ïŒã©ã¡ããåçºé²æ¢ã«æçšãïŒ cq4-9 èéèç€ã«å¯ŸããŠãã«ãŒã³äžéè¡æ§çµéèçéèç€å¡æ è¡ïŒb-rtoïŒã¯æå¹ãïŒ.çŽè žéèç€ã®è¡è¡åæ ããã³ãã®æ²»çæŠç¥ ç°ç æä¹ 1ïŒæ æèïŒä»æ 最1ïŒæšæ å ¬å1ïŒäœäŒ¯ ä¿äž1 åœç§ã§æ²»çãæœè¡ããçŽè žéèç€19 äŸã察象ã«ïŒçŽè žéèç€ã®è¡è¡åæ ããã³ãã®æ²»çæŠç¥ã«ã€ã.æ£ãå¥ã»åéèã®æ¡åŒµãæ¥ããåŸããïŒæãããªç€ç¶ã® æ¡åŒµãåãããšããå ±åã¯æ¯èŒççšã§ãã6ïŒ7ïŒïŒ æ¬çäŸã§ç¹ã«éå¥äžéèŠãšãªãçŸæ£ã«äœéèå¥åœ¢ãäœ éèåæµç°åžžãªã©ã®éèç³»ã®å 倩ç°åžžãæããããïŒå·Š.çŽè žéèç€ã®çºçé »åºŠã¯ããŸããŸã§ããã, ãšãã«å€§åºè¡ãæ¥ãå±éºæ§ã®ããç æ ã§ãã.çŽè žéèç€ã®è¡è¡åæ 蚺æã«ã¯å èŠé¡çè¶ é³æ³¢åã©ãŒããã©æ³ãæçšã§ãã.æ²»çã¯, æè¿ã§ã¯å èŠé¡æ²»çãäžå¿ã§, å èŠé¡ç硬åçæ³ãå èŠé¡çéèç€çµçŽ®è¡ãè¡ãããããšãå€ã.çŽè žéèç€ã¯ãããŸã§.äžè¢éèç€ã®äžã§æãçç¶ãéãã±ãŒã¹ã§ã朰çããã§ããŸããã§ã¯ãªãäžè¢éèç€ã§æœ°çãã§ããŠããŸãã®ã§ããããïŒããã§ã¯äžè¢éèç€ã«æœ°çãã§ããã¡ã«ããºã ãäžè¢éèç€ã®æ€æ»æ¹æ³ã»æ²»çæ³ã«ã€ããŠè©³ãã解説ããŠããŸãã.粟玢éèç€ã¯ã粟巣æ©èœã«åœ±é¿ãäžãã粟åãé ãæ©èœãäœäžãããã粟åã®dnaã®æå·ãæããç·æ§ãã«ã¢ã³ã®äœäžãåŒãèµ·ãããŸãããä¹ç²Ÿåçã»ç²Ÿåéåçäœäžãã®35ïŒ ã®æ¹ã粟玢éèç€ãåå ã§ã2人ç®äžåŠã®78ïŒ ã®åå ã粟玢éèç€ãšèšãããŠããŸãã.Q5 Cåè硬å€ã¯ã©ã®ããã«èšºæããæ²»çããã®ã§ããïŒ éèå§äº¢é²çã®åå ã®çŽ90ïŒ ãè硬å€ã§ãããããã«äŒŽã£ãŠé£éã»èéèç€ãéè ããã«åçºãããªãæ¹æ³ãšããŠã1é±åŸã«ã¢ã«ãŽã³ãã©ãºãååºæ³ïŒAPCïŒã«ããå°åºãæ³ãè¿œå ãããšæçšã§ãã.é£éã»èéèç€ é£éã»èéèç€ã¯ãéèãŒå€§åŸªç°ç³»ã«çããåŽå¯è¡è¡è·¯ã§ããã âçºçã«ã¯éèå§ã®äžæãé¢äžããïŒ12mmhg以äžïŒ éèå§äº¢é²ããããçŸæ£ è硬å€ãªã©æ ¢æ§èçŸæ£ ãŠã€ã«ã¹æ§èç(hbv, hcv) åçºæ§èæ±æ§è硬å€(pbc) åçºæ§ç¡¬åæ§è管ç(psc).
-> éèç€ããããè¬
äžè¢éèç€ã®æ²»çã«ã¯ "ä¿åçæ²»ç"ã"硬åçæ³"ã"æè¡"ã"è¡ç®¡å æ²»ç"ã®ïŒã€ã 硬åçæ³ã¯è»œçã®äžè¢éèç€ã«ã¯æçšæ§ã®é«ãæ²»çæ³ã§ãããé²è¡ããéèç€ã«ã¯Â .åšè¡æäžå€§éèãã£ã«ã¿ãŒç眮ãæçšã§ãã£ã å€è¡çå䜵äžè¢éèç€ã®å€ç§æ²»ççµéš 氎沌 åä¹* æ¥ç° çŽæš¹ æ°å 亮 åå åŠ è® éäžé èŠ æšïŒçæ§å€è¡çãå±éºå åãšèããããè¡šåšæ§è¡æ éèçãå䜵ããå³äžè¢éèç€.è硬å€ã«ãªã£ãŠããŸã£ãæ¹ã亡ããªãåå ã§äžçªå€ãã£ãã®ã¯é£ééèç€ã§ãããããã§ããä»ã§ã¯æè¡ãé£ééèç€ã®ã³ã³ãããŒã«ã®æ¹æ³ãé²åããŠæ»äº¡çã¯äžãã£ãŠããŸãããæ¥åžžç掻ã§ãæ°ãã€ããªããã°ãããŸãããç¹ã«é£éã®ç æ°ãªã®ã§ãé£äºã«å¯Ÿããã±ã¢ã¯æ¬ ãããŸããã.æ±äº¬è¡ç®¡å€ç§ã¯ãªããã¯ã§ã¯ãææ°ã®ã¬ãŒã¶ãŒã«ããäžè¢éèç€ã®æ²»çãè¡ã£ãŠãããŸããæ£è æ§ãå®å¿ããŠäžè¢éèç€ã®æ€æ»ãæ²»çãæè¡ãè¡ã£ãŠé ããããçµéšè±å¯ãªå°éå»ãã¯ãããäžæµã®ã¹ã¿ãããæ²»çã«åãçµã¿ãŸãã.森ä¹å®®ç é¢ã¯ãäžè¢ïŒè¶³ïŒã®åèçŸæ£ãéèçŸæ£æ²»çã«ç¹åããç é¢ã§ãã足ãéã ããã»ããããããã»è¶³ã®éèããŒããŒãããŠããã»è²çŽ æ²çã»çã¿âŠãã®ãããªçç¶ãã¿ãããå Žåãäžè¢éèç€ãçºçããŠããå¯èœæ§ããããŸãããã®ããŒãžã§ã¯äžè¢éèç€ã®çç¶ãããã®æ²»çæ¹æ³ã«ã€ã.èéšéèç€ã¯ãè¡æ¶²ã®æµããæ¹åãéæµããããšãé²ãããã«éèã®äžã«ããåŒãæ£ããåããªãããšãåå ã§èµ·ããã®ã§ããè¡æ¶²ã¯ãã®ãããªåŒã®æã§æºãŸããéèãæ¯çŽ°è¡ç®¡ã®è¿ãã§æ»çããŠèšåŒµããè¡æ¶²ã液äœããã®åšãã®çµç¹ãžæŒããŠè¡ããŸãã.CQ3-01éèå§äº¢é²çã®èšºæã«è ¹éšCT(MDCT)ã¯æçšãïŒMDCTangiographyã¯éèå§äº¢é²çã«ãããåŽå¯è¡è¡è·¯ãèéèç€ã®èšºæã«æçšã§ããã3D-CTã¯é䟵襲çæ€æ»ã§ããè ¹éšè¡ç®¡é 圱æ€æ»ã«ãšã£ãŠä»£ããããAæµ·å€IIbæ¥æ¬Ibä¿éºå¯CQ3-02éèå§äº¢é²çã®èšºæã«è ¹éšMRI,MRAã¯æçšãïŒ.èéèç€ã®æ²»çã¯ãéèç€ã®ç¶æ ã«ããããŸãããè硬å€ãããéèç€ãæªç Žè£ã§ããã°ããŸãã¯èèã®ççãæããèåºè·ïŒã²ãïŒçæ³ãèç²èä¿è·ãåªå ããŸããå¿ èŠã§ããã°åºè¡ã®äºé²çåŠçœ®ãšããŠãèéèç€ã«çŽæ¥çãªæ²»çãè¡ããŸãã.è¢éèç€æ£è ã«ãããŠæ€èšãè¡ã£ãã 察 象 å¥åžžçŸ€ãšããŠã¯ïŒå¥åžžè ããã³éèçŸæ£ãæããªã èŠ æšïŒæ·±éšéèè¡æ çã®çåŠçäºé²æ³ã®ã²ãšã€ã§ããéæ¬ ç空æ°å§è¿«æ³ã¯ïŒåœ¢æ ïŒå§è¿«éšäœïŒ.
-> 粟油ãéèç€ã«åœ¹ç«ã€ããš
è¡ç®¡ã®ã¯ãªã åèç€ã»äžè¢éèç€ã»ãšã³ãããŒã¯ã©ã¹çå矀ã»ãªã³ãæµ®è «ã 2017.04.15 å¥è¯åž å¥è¯ç; ä»äºåŽè£ïŒç¬¬45åæ¥æ¬è¡ç®¡å€ç§åŠäŒåŠè¡ç·äŒ ãæç³»åã§ã¿ãåœé¢ã«ãããäžè¢éèç€ã®è¡åŒéžæã®å€å ïŒã¹ããªããã³ã°è¡ã¯ãªããªãã®ãïŒ.éèç€ãã©ããã¯ãç«ã£ãŠããã足ãèŠãã°ããããŸãããã©ã®éèã«èµ·ããŠããããåå ã¯äœãã調ã¹ãŠãæ²»çããå¿ èŠããããŸãããããŸãå°éå»ã®èšºå¯ãåããŠãã ããã ãšãã«ãéèè¶ é³æ³¢æ€æ»ãæçšã§ãå°éã®å»åž«ãæåž«ã«æ€æ»ããŠããã.äžæ°éã®éå¡ã«ãã£ãŠãããç¡åŒåžã»äœåŒåžç¶æ ã«ãªãçç¶ã®ããšã§ãã ã§ããåœç¶ã§ããéèç€ã¯æ±æžæ代ãæ©ã¿ã®çš®ã ã£ãã®. ã§ãããã£ãšããã°éèç€ã®æè¡ã®Â .ãªãªãã³ïŒãµã€ãªãŠã ïŒã¯ å šèãçš®åã«å€ãã®æçšãªå¹æ ãæã€ãšãããŸããè±æã«è»åèãæ¡åããæ¥å¹²ãã«ããŸããç§ã«å°äžéšãåããæ¥å¹²ãã«ããŠçš®ãéããŸãã䜿çšéšäœã¯ä¹Ÿç¥ãããæççš®åããã³çš®åã®å€åŽã®èãèã«ãªã£ãŠããå€ç®ã.ã¯ã¢ã®å·£ç¶éèç€ã¯ãèã®èŠãç®ããšãŠãæªããªããããéåžžã«å«ãªãã®ã§ãããã®åå ã¯ããŸããŸã§ãæ²»ãããã«ã¯ãéäžçãªæ²»çãå¿ èŠãšãªã£ãŠããŸããŸãããã®èšäºã§ã¯ãå¹æçã«ã¯ã¢ã®å·£ç¶éèç€ã解æ¶ããããã®æ¹æ³ã«ã€ããŠã玹ä»ããŸãã.æè¡ã«ãã䟵襲ã®çšåºŠãå°ãããäžå®ã®åœ¢ã®ç€ã§ããã°ãã€ãªã¹ã¯ãªæ¹ã«ãã¡ãªããã倧ããæçšãªã®ã§ããããšã³ããªãŒã¯ãšåŒã°ããåèç€å ãžã®è¡æ¶²ã®æŒãããã¹ãã³ãã°ã©ããã®äœçœ®ç§»åã»å±æ²ã»ç Žæãé éæã®ç€æ¡å€§ã»ç Žè£ãªã©ãä»åŸæ¹åãã¹ãç¹.粟玢éèç€ã®æ€æ»ã¯ã觊蚺ãèŠèšºãè¶ é³æ³¢ãçšããŠè¡ãããŸãã粟玢éèç€ã®æ€æ»è²»çšã¯2ïœ3äžåãçžå Žã®ããã§ããæ€æ»ã®çµæãéèç€ã®çšåºŠã¯ä»¥äžã®3段éã«åé¡ãããããããã®ã°ã¬ãŒãã«ããæ²»çå 容ã決å®ãããããã§ãã.éèç€ã®å Žåãå°ããã€ãã®30mmHgå°ã®ã¹ãããã³ã°ãå±¥ããŸãã è è ¹çãå§è¿«ãåçž®åãé«ããçèã®ãã³ãäœçšã匷ããã è¡šåšéèãå§è¿«ããéèè¡ã®éæµéãæžããã 埮å°åŸªç°ãæ¹åãããã 1ïœ3ã®äœçšã«ãããéèç€ã®çç¶ãæ¹åããé²è¡ãäºé²ã.2ïŒé£éã»èéèç€åºè¡ã«å¯ŸããŠãã«ãŒã³ã¿ã³ãããŒãã¯æå¹ã. p59 F-3ïŒé£éã»èéèç€æ²»çã«å¯ŸããŠå èŠé¡æ²»çã¯æå¹ãïŒ p61 F-4ïŒèéèç€ã«å¯ŸããŠ. B-RTO ã¯æå¹ãïŒ p62 F-5ïŒèéèç€åºè¡ã«å¯ŸããŠcyanoacrylate ç³»è¬å€æ³šå ¥æ³ã¯æå¹ãïŒ p64 F-6ïŒè£å©çæ³ãšããŠã®.
-> éèç€ããã®ãªã³ãŽé ¢ã®äœ¿çš
éèè¡æ çãäžè¢éèç€ã®èšºæã«æçšãªæ€æ»ã§ãã ç®çéšäœïŒäžè¢ïŒäžè éèãæ©éªšéèã尺骚éèïŒãäžè¢ïŒç·è žéªšéèãå€§è ¿æµ ã»æ·±éèã倧äŒåšéèãè窩éèãå°äŒåšéèãåã»åŸè骚éèãè 骚éèãã²ããéèãè è ¹éèïŒ.æ€æ»æ¹æ³ äžè¢éèç€ã®æ€æ»æ¹æ³ å»åž«ã«ãã蚺å¯ã®ä»ã«ãè¶ é³æ³¢æ€æ»ïŒãšã³ãŒæ€æ»ïŒããšãŠãæçšã§ãã è¢éèç€ã¯ããã€ãã®ã¿ã€ããããããšã³ãŒæ€æ»ã§ãããã®ã¿ã€ããæ£ç¢ºã«èŠæ¥µããããšãåºæ¥ãŸãã.ãã®èšäºã¯æ€èšŒå¯èœãªåèæç®ãåºå žãå šã瀺ãããŠããªãããäžååã§ãã åºå žãè¿œå ããŠèšäºã®ä¿¡é Œæ§åäžã«ãååãã ãããïŒ2018幎5æïŒ. éèç€ïŒãããã¿ãããã ããè±: varicose veinïŒãšã¯ãéèã®å£ã®äžéšãäœããã®èŠå ã§èããªãããã®Â .2018幎4æ13æ¥ éèç€ãäžè¢ã«èµ·ãããããã®ã¯ãå¿èããé ãäœçœ®ã«ããããšãã人ãç«ã£ éèç€ã«ã¯äœãçç¶ããªãããšãå€ãã®ã§ãããè¡šïŒã®ãããªçç¶ãåºã .ãåµå·ã»è€¥ç¡ã»ç±å·ã¬ã€ãã©ã€ã³â5:äžè ¿æœ°çã»äžè¢éèç€èšºçã¬ã€ãã©ã€ã³ãã®Mindsæ²èŒããŒãžã§ããäœææ¹æ³ã®èŠ³ç¹ãã質ã®é«ã蚺çã¬ã€ãã©ã€ã³ãšè©äŸ¡ãããŸãããç£ä¿®ïŒæ¥æ¬ç®èç§åŠäŒãç·šéïŒåµå·ã»ç±å·ã¬ã€ãã©ã€ã³å§å¡äŒãçºè¡å¹ŽïŒ2017幎ãçºè¡ïŒæ¥æ¬ç®èç§åŠäŒ.èºè¡æ å¡æ çããã³æ·±éšéèè¡æ çã®èšºæã»æ²»çã»äºé²ã«é¢ããã¬ã€ãã©ã€ã³ Classâ ¢ïŒæ€æ»ã»æ²»çãæçšã§ãªãïŒãšãã«æ害ã§ãã äžè¢éèç€.éèç€ã¯èŠãç®ãããŸããããªãããè¡ã®æµããæªããªãã®ã§ã足ã®ã ãããã€ããæãããããå°ãªããããŸããã ããã§ã¯ãéèç€ãä¹ãè¶ããããã®äœéšè«ãšãšãã«ããã¯ã¿ãŒã«èããéèç€ã®ã¡ã«ããºã ãã»ã«ãã±ã¢æ¹æ³ãã玹ä»ããŸãã.èéèç€ã¯å èŠé¡ã«ãã£ãŠæ€æ»ããããå èŠé¡ã¯æè»ãªå ãã¡ã€ããŒã«ã¡ã©ã§ãããèã«æ¿å ¥ãããnbcaã¯ãå èŠé¡ãéããŠéèã«æ¿å ¥ãããã«ããŒãã«éã§æ³šå ¥ããããä»ã®éšäœã®éèç€ãšããŠã¯ãé£ééèç€ ãåäºæè žéèç€ ãå€§è žéèç€ ããããã.äŒåšéèç€ãã¯ïŒäžè¢ã®å åŽããµããã¯ããèµ°ã倪ãè¡šåšéèã§ããã倧äŒåšéèãããå°äŒåšéèãã«éæµã éèç€ã®æ²»çãå¿ èŠãšããã®ã¯ä»¥äžã®ãããªå Žåã§ãã.
Éèç€ã®çš®åã¯æçšã§ããïŒ:
Rating: 381 / 595
Overall: 117 Rates